Keywords: DRD2; dopamine receptor 2; attention deficit hyperactivity disorder (ADHD)
The relationship of the DRD2 TaqI-A1 allele to hyperactive/impulsive and inattentive symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents was examined in a sample of clinic-referred children and their siblings, and control children and their siblings (n = 236). The contribution of genetic dominance and additivity to mean differences among the A2A2, A1A2, and A1A1 genotypes was estimated using structural equation modeling. The effect of genetic additivity was statistically significant for both traits in an analysis of all children. The heritability from the DRD2 locus was estimated at 4.27% for hyperactiveimpulsive symptoms and 2.12% for inattentive symptoms. Children with the A2A2 genotype had the highest mean level of symptoms. To control for any possible effects of population stratification, this analysis was repeated with parental genotypes as controls. In this smaller sample, although the direction of the effect was the same as that in the whole sample, the genotypic differences failed to reach conventional significance levels and the effect sizes were smaller (h 2 = 1.62% and 0.79%, respectively). Furthermore, a genotype relative risk test of children who had questionnaire-based diagnoses of ADHD also failed to yield evidence of either association or linkage. Given that the A1 allele was expected to be the high risk allele, and that results were non-significant in tests that controlled for population heterogeneity, we doubt that this DRD2 polymorphism influences symptoms of ADHD in childhood.
The dopamine receptor 2 gene (DRD2) has been the focus of considerable research linking genetic polymorphisms with behavioral traits. The most frequently studied mutation in DRD2 is a TaqI restriction site in the 3Ј untranslated region of the gene. 1 It does not alter the amino acid sequence of the DRD2 protein, and its functional significance, if any, is unknown. This study examines the relation of the TaqI polymorphism to symptoms of hyperactivity-impulsivity and inattention, the symptom dimensions that underlie DSM-IV diagnoses of attention deficit hyperactivity disorder (ADHD).
There is reason to expect genes in dopaminergic brain pathways to be related to childhood ADHD. The dopaminergic pathway mediates responsiveness to reward and is implicated in the rewarding action of abused drugs such as cocaine and alcohol. 2, 3 Further evidence for the importance of the dopaminergic pathway to ADHD comes from a knockout-gene study in mice. 4 In this study, mice that were homozygous for deactivation of the dopamine transporter gene (DAT1) were five to six times more active and had dopamine remain active in the synaptic cleft 100 times longer than heterozygous and wild-type mice. In our previous work, we found association and linkage between ADHD and a polymorphism in DAT1 and association between ADHD and another polymorphism in the dopamine receptor D4 gene (DRD4). 5, 6 There was also some evidence for heterogeneity in the relation of these genes to ADHD symptoms. DRD4 was more strongly associated with the inattentive symptoms than with the hyperactive symptoms of ADHD, whereas DAT1 was associated and linked with the ADHD combined subtype but not with the inattentive subtype. Other studies also verify an association between these polymorphisms and ADHD. [7] [8] [9] Previous research has suggested that the DRD2 A1 allele may be a risk allele inducing ADHD. Comings' research group has twice investigated the relation of the DRD2 A1 allele to ADHD diagnoses and symptoms. In one study, they sampled 108 ADHD children, 28 of whom had a family history of Tourette's syndrome. 10 Comings et al found that the DRD2 A1 allele was present (ie, in A1A1 + A1A2 genotypes) in 49% of ADHD children vs 25% of control children. In another study of the DRD1 and DRD2 genes, the Comings' group used a questionnaire-based measure of DSM-IV ADHD symptoms, as we do in this study. 11 Thus, they treated ADHD symptoms as a continuous trait rather than as a diagnostic category. They found that ADHD symptoms correlated positively with the A1 allele of DRD2. Thus, we expected a similar association to be found in our sample.
Comings et al's studies examined association using a between-families design, however, which creates the possibility of a population stratification confound. In our study, we obtained genotypes from the children's parents that we used to group children by parental mating type. Thus, we can extend Comings et al's findings by investigating association and linkage of the DRD2 A1 allele with ADHD symptoms using within-family analyses that avoid the potentially biasing effects of population stratification. In this study, we model the ADHD symptom means in terms of the additive and dominance genetic effects of DRD2, first without controls for population stratification and second using parental mating types as controls for any possible stratification effects.
To test whether the DRD2 polymorphism was significantly related to the ADHD symptom counts, we used structural equation modeling of the phenotypic means for each genotype to estimate genetic additive and dominance parameters. 12, 13 This approach resembles an analysis of variance (ANOVA) of the ADHD means for each genotype. The approach, however, offers advantages over ANOVA in that it can accommodate different variances for different genotypes and also yields estimates of additive genetic and dominance genetic parameters that have clear genetic interpretations. The significance of the DRD2 polymorphism's effect is tested by examining the deterioration in fit when the genetic parameters in the model are fixed to zero.
The tests for ADHD symptom mean differences by genotype group were performed with and without parental mating types as controls. To explain the approach for the situation without parental mating types as controls, let o be a constant that is the same for all genotype groups, g j the effect of the genotype on the ADHD symptom count, and r ij the residual score of subject i with genotype j, consisting of the effects of other unlinked loci and environmental factors. The symptom count x ij of subject i with genotype j can then be written as:
The DRD2 TaqI polymorphism consists of the high risk A1 allele and the low risk A2 allele. With this biallelic representation there are three genotypes. To model the effects of these genotypes the parameters discussed by Falconer and Mackay 14 were used in which a score a is assigned to the A 1 A 1 genotype, d to the A 1 A 2 genotype, and −a to the A 2 A 2 genotype. Thus, the genotype effects are expressed on a scale where both homozygote genotypes have scores that differ from the scale mean, which equals o, by the factor a corresponding to the additive genetic effect. The parameter d, representing the dominance effect, is the discrepancy of the mean for the heterozygote from the average of the means for the two homozygote genotypes.
The first column of Table 1 shows the means in the three genotype groups. The means can be computed by taking the expected value of Formula 1. This analysis assumes that the residual effect is uncorrelated with the genetic effect so that the residual variances are estimated separately from the means. The program Mx 15 was used to obtain maximum likelihood estimates of a and d.
The estimates of a and d can be used to calculate the variance explained by the locus: (2) in which N is the total sample size, n j the size of the group with genotype j, x j the mean in genotype group j as specified in Table 1 3 ), the model is just identified (ie, has zero degrees of freedom). To test for the significance of the additive, dominance, or total genetic effect of the locus, parameters a, d, or both a and d need to be fixed to zero. The test statistic is 2 distributed with the number of fixed parameters as its degrees of freedom.
The DRD2 allele frequency is known to vary widely among ethnic and racial groups. 16, 17 Although the prevalence of ADHD by ethnic and racial groups is less well established, it is potentially different among them. Thus, the relation of the DRD2 A1-allele is possibly biased by population stratification effects. This stratification confound would bias an association test without parental mating types as controls (ie, as in Equation 1). In an association test using parental mating types as controls, however, any effects of population admixture can be partialled out because population admixture can only result in differences between parental mating types. Once admixture effects are taken into account by conditioning on the parental mating type, unbiased estimates of genetic effects can be obtained by examining whether subjects with different genotypes within parental mating type groups with at least one heterozygote parent differ in their average trait scores. To specify the test with parents as controls, the contribution of genotype j has to be written as g j = g k + g′ jk , where k indicates the mating type group. Thus, the genotype effect g j is divided into the mean genotype effect g k in group k plus the deviation gЈ jk of genotype j from the mean in mating type group k. In addition to the genetic contribution, the mean in each mating type group will also be affected by the constant o and a possible effect of population admixture effect m k that will differ for each parental mating type group. The total mean in mating type group k therefore equals o k = o + g k + m k Substituting o k in Formula 1 gives:
With two alleles there are three mating types that include at least one heterozygote parent. The means of the possible genotypes within each mating type are shown in the second part of 
model and the 2 of the full model, and is distributed as 2 with the number of fixed parameters as the degrees of freedom. Heritabilities can be obtained by substituting a and d into Formula 2.
DRD2 genotypes were determined for 164 children from 125 families visiting the Center for Learning and Attention Deficit Disorders in Atlanta or a psychiatric office in Tucson and 72 children from 53 general population families. Genotyping of DRD2 was also completed on 161 mothers and 121 fathers. The sample of 72 non-referred children and siblings is hereafter identified as the control sample; the sample of 164 referred children and their siblings from psychiatric settings is hereafter identified as the clinic sample. For all 236 children (192 males, 44 females), the average age was 10 years (SD = 2.8 years). Their genotypic frequencies were A1A1 0.017 (n = 4), A1A2 0.326 (n = 77), and A2A2 0.657 (n = 155). The frequency of the A1 allele was 0.18.
The means and variances of the ADHD symptom counts for these 236 children are shown in Table 2 . The Table 3 shows the parameter estimates and heritability due to the DRD2 polymorphism in our sample of clinic-referred and control children. Because a represents the value of the A 1 A 1 genotype and −a the value of the A 2 A 2 genotype, the negative values of a indicated that the A 1 allele was associated with lower symptom counts. In all situations the dominance score was very small. The heritabilities were larger for HyperactiveImpulsive than for Inattentive symptoms. For the tests that used parental mating types as controls, heritabilities were consistently smaller. Table 4 shows the results from the 2 difference tests that examined whether the genotype effects were significant. Most tests were not significant. An exception was the test for Hyperactive-Impulsive symptoms in the situation without parents as controls, where the test for the additive genetic parameter a as well as the overall test (a and d) were significant. We should also mention that we performed the test for total genetic effects with two degrees of freedom. However, an a priori assumption of no dominance or a sequence of tests in which non-significant dominance effects are fixed to zero first, would yield a test with one degree of freedom because genetic effects can then be tested by fixing only the additive genetic parameter a to zero. With one degree of freedom the result for additive genetic effects on Inattentive symptoms in the situation without parental mating types as controls was also significant ( 2 = 5.395, df = 1, P = 0.020). For the situation without parental mating types as controls, it can be shown that our quantitative test involving the means in the genotype groups is more powerful than a test that examines whether the frequency of the genotypes are equal in the groups of cases and controls. 13 In contrast, for the situation with parental mating types as controls, the quantitative test we used can be less powerful than its categorical counterpart, which is known as the genotype relative risk method (GRR). 18 This method tests two relative risks for a trait: (1) the relative risk for homozygotes with two copies of a candidate gene vs the homozygote without the candidate gene; and (2) the relative risk of heterozygotes with one copy of the candidate gene vs the homozygote without the candidate gene. This GRR method eliminates spurious effects resulting from population stratification. We applied the GRR method only to children in the clinic sample with a diagnosis of ADHD, with at least one parent who was a DRD2 heterozygote, and with genotypes available for both parents (n = 26). This method tests whether the different genotypes have equal probabilities of being diagnosed with ADHD, conditional on the parental mating type. The saturated model comprises two relative risks, namely 1 which represents the increased chance of being diagnosed with ADHD, for the A 1 A 1 homozygote with two copies of the candidate gene vs the A 2 A 2 homozygote without the candidate gene, and 2 which represents the increased chance of being diagnosed with ADHD for the A 1 A 2 heterozygote vs the A 2 A 2 homozygote. A special case of this test involves the constraint 2 = 1 2 which yields the maximum likelihood version of the transmission disequilibrium test (TDT) 19 that examines the preferential parental transmission of one allele over the other.
To test the null hypothesis assuming no genetic effects the relative risks need to be fixed to one. Under the null hypothesis, twice the difference between the log-likelihood with 1 and 2 as free parameters and the log-likelihood of the null model with 2 = 1 = 1.0 has a 2 distribution with the number of relative risks fixed to 1 as the degrees of freedom. To evaluate the likelihoods an iterative procedure is required, for which we used Mx. Results showed that the test that constrained both relative risks ( 2 = 0.67, df = 2, P Ͻ 0.71) as well as the TDT that involved one relative risk ( 2 = 1.264, df = 1, P Ͻ 0.26) were not significant. This confirmed our quantitative test with parental mating types as controls in suggesting no significant effects of the DRD2 TaqI polymorphism.
None of the results with the test that included parental mating types as controls were significant. Partly this can be explained by the smaller sample sizes that resulted from the fact that only subjects with at least one heterozygous parent can be used. However, the heritabilities reported in Table 3 were also lower with this test. Such a pattern is in principle consistent with the effects of population admixture. Because population admixture disrupts Hardy-Weinberg equilibrium, we examined whether the frequencies of the genotypes A 1 A 1 , A 1 A 2 , and A 2 A 2 were equal to p 2 , 2pq, and q 2 in the children and their parents. A 2 test based on the genotypes of the children (n = 236, 2 = 2.594, df = 2, P = 0.273) as well as a 2 test that was based on the genotypes of their parents, assuming that there was no assortative mating, so that the genotypes of the mother and father could be treated as independent observations (n = 391, 2 = 1.347, df = 2, P =0.510) were not significant, thus implying that the genotypes were in Hardy-Weinberg equilibrium. This finding yielded strong support for the hypothesis that population admixture did not cause the significant result for Hyperactive-Impulsive symptoms in the analysis without parents as controls. This conclusion is based on the fact that given our heritability and sample size, the 2 test for Hardy-Weinberg equilibrium has the statistical power to show a departure from equilibrium. 13 We can identify three possible interpretations for the association of the A2 allele with Hyperactive-Impulsive and Inattentive symptoms in our sample: (1) population admixture; (2) a Type I error; and (3) a real effect due to a functional polymorphism near the DRD2 TaqI polymorphism. Our results on population admixture were ambiguous. In support of population admixture effects, the heritabilities with parental mating types as controls were about half the value of h 2 estimates unconditioned on parental mating types (HyperactiveImpulsive, 4.27% vs 2.12%; Inattentive, 2.12% vs 0.79%). The reduction in the strength of association could be explained by population admixture. On the other hand, admixture also demands genotype frequencies that are not in Hardy-Weinberg equilibrum. The Hardy-Weinberg test had sufficient statistical power to detect any population admixture effects when the test for genetic additivity would yield a false positive result, given our sample size, allele frequencies, and heritability estimate. Thus, we doubt that population admixture is the best explanation for our results.
The reduction in the effect size between an unconditioned analysis and one conditioned on parental mating types was probably an effect of sampling variation due to the reduction in sample size in the latter tests.
A second hypothesis is a Type I statistical error such that no relationship exists in the population, but we by chance drew a happenstance sample with a relationship in it. The absence of other reports of A2 associations may be an instance of the 'file drawer' problem, as researchers may withhold their A2 associations or null findings from publication, regarding them as too discrepant with the existing literature. We favor this explanation because of the inconsistency of the results surrounding the TaqI-DRD2 polymorphism (eg, the many non-replications of the DRD2 A1-alcoholism association). 20, 21 A third explanation is that this result is a real one and that a functional polymorphism exists near the DRD2 TaqI polymorphism. Two research groups recently tried to replicate an association of the DRD2 A1 allele and lower DRD2 receptor-binding potential. Pohjalainen et al found an association of the A1 allele with a decrease in receptor-binding potentials. 22 In contrast, Laruelle et al found no association of receptor-binding potential with the DRD2 A1 allele. 23 In their normal controls, however, the direction of the result was decreased binding potential for A1A2 genotypes vs A2A2 genotypes, as found by Pohjalainen et al (the rare A1A1 genotype could not be evaluated). In a review of both papers, 24 Hitzemann argued, based on data from mouse linkage studies of DRD2 receptorbinding potential, that the majority of variation in receptor density is due to genes that lie elsewhere from DRD2 in the genome, but that a polymorphism that affects receptor density also may exist in or near the mouse DRD2 gene.
Therefore, another way to reconcile our results with those of Comings' research group is to suggest that different haplotypes exist containing either the A1 or A2 alleles in linkage disequilibrium with a functional polymorphism. This reasoning would allow either allele to 'pick up' an association with behavioral traits, and results could vary depending on the histories of admixture in different populations. 25 However, without further evidence of a functional site and demonstration of within-family association, this explanation is also highly speculative. We believe that the DRD2-A2 association with ADHD in our sample is most likely a chance result due to sampling error and is not indicative of a causal influence of the polymorphism (or closely linked polymorphism) on symptoms of ADHD.
Methods

Subjects
Data were collected at two research sites: Tucson, Arizona and Atlanta, Georgia. At the Tucson site, children in the control sample were ascertained through a list of families in the general population with at least one male child 8-12 years old generated by Multi-Media, a market research firm. Any male sibling 6-16 years old was also sampled. Clinic-referred boys in Tucson were identified through psychiatrists in private practice. At the Atlanta site, only clinic-referred children (both males and females) were sampled through the Center for Learning and Attention Deficit Disorders (CLADD) at Emory University's School of Medicine. At this site, siblings also were sampled whenever possible.
Diagnostic assessment
At the Tucson site, an interviewer visited each family in their homes. After obtaining informed consent, the mother was interviewed about household composition. The mother and father next completed questionnaires on demographic characteristics and behavior problems in their children (see below). The family session ended with the collection of buccal cells using a watermouthwash procedure. At the Emory site, a few families were seen at CLADD, although the majority of families were seen in their homes. The data collection sessions followed much the same sequence as in Tucson.
The mother provided demographic data on a short questionnaire, and both parents rated their children for behavioral problems on the Emory Diagnostic Rating Scale (EDRS). This questionnaire was developed to assess symptoms of the major DSM-IV childhood disorders. Each symptom of these disorders was translated into an item on which children were rated by their parents on a 0-4 scale, with 0 being not at all characteristic of their child and 4 being very much characteristic of their child. In this study, scores on the hyperactiveimpulsive and inattentive symptom dimensions of ADHD were analyzed. The 0-4 scores for each symptom were summed for each of the nine items making up the hyperactive-impulsive and inattentive symptom dimensions, yielding continuous symptom-scale scores for each individual.
For each symptom dimension, the symptom levels based on mother's and father's ratings were averaged to produce a more reliable composite symptom rating. This procedure was justified by the high correlation between mother's and father's ratings (hyperactive, r = 0.80; impulsive r = 0.72; and inattentive, r = 0.83).
The EDRS also yields questionnaire-based diagnoses of the ADHD subtype disorders in addition to the continuous symptom-scales. A diagnosis was assigned if a child surpassed the standard diagnostic thresholds (ie, Ն6 of 9 symptoms) on the inattention and/or hyperactivity symptom dimensions. Children were given an ADHD diagnosis if they surpassed the diagnostic threshold on inattention symptoms, hyperactive-impulsive symptoms, or on both types of symptoms.
Genotyping
Buccal cell samples from family members were returned to University of Arizona's Laboratory of Molecular and Systematic Evolution, a multi-user lab facility. DNA was extracted using a low/high salt procedure. Genotyping of the DRD2 TaqI polymorphism was completed followed a standard protocol. 26 For genotyping, DNA stained with ETBr was visualized on agarose gels.
